As Eli Lilly rolls ahead with a $27 billion investment to prop up four new manufacturing facilities in the U.S, the company ...

ABC News Medical Correspondent Dr. Darien Sutton take a closer look at the new study by Eli Lilly that their popular diabetes ...

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.

Candymaker Mars pledges $2 billion for domestic operations through 2026, building on $6 billion invested over the past five ...

Asian shares are lower after choppy trading on Wall Street that saw more losses as investors assess President Donald Trump’s ...

A backlash against a White House video promoting deportation and Casalonga opening a new office in Düsseldorf were also among the top talking points ...

Empower Pharmacy, a Houston-based compounding pharmacy, has been sanctioned by the FDA and other states in the past decade.

In past seasons, Missouri football has produced some highly skilled players at the edge rusher position. Darius Robinson was ...

Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type ...

Eli Lilly (LLY) stock in focus as its diabetes drug Mounjaro causes heart benefits suceeding in a late-stage trial versus its ...

One of the more popular stocks in the pharmaceutical sector of late got the cold shoulder from investors on Tuesday. Eli Lilly ( LLY 2.95%) closed today's trading session down by almost 6% in value, ...